BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30673678)

  • 1. Blockade of Serotonin 2C Receptors with SB-242084 Moderates Reduced Locomotor Activity and Rearing by Cannabinoid 1 Receptor Antagonist AM-251.
    Bogáthy E; Kostyalik D; Petschner P; Vas S; Bagdy G
    Pharmacology; 2019; 103(3-4):151-158. PubMed ID: 30673678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of 5-HT2C and CB1 receptor blockade on the regulation of sleep-wake cycle.
    Bogáthy E; Papp N; Tóthfalusi L; Vas S; Bagdy G
    BMC Neurosci; 2019 Mar; 20(1):14. PubMed ID: 30894126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of combination treatment with leptin and cannabinoid CB1 receptor agonist on food intake and body weight gain is mediated by serotonin 1B and 2C receptors.
    Wierucka-Rybak M; Wolak M; Juszczak M; Drobnik J; Bojanowska E
    J Physiol Pharmacol; 2016 Jun; 67(3):457-63. PubMed ID: 27512006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors.
    Soria-Gómez E; Márquez-Diosdado MI; Montes-Rodríguez CJ; Estrada-González V; Prospéro-García O
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1247-54. PubMed ID: 20663269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.
    Zayara AE; McIver G; Valdivia PN; Lominac KD; McCreary AC; Szumlinski KK
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):321-35. PubMed ID: 20814782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration.
    Vicente MA; Zangrossi H
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):389-400. PubMed ID: 21733232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys.
    Manvich DF; Kimmel HL; Cooper DA; Howell LL
    J Pharmacol Exp Ther; 2012 Sep; 342(3):761-9. PubMed ID: 22685342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT
    McLaughlin PJ; Jagielo-Miller JE; Plyler ES; Schutte KK; Vemuri VK; Makriyannis A
    Psychopharmacology (Berl); 2017 Mar; 234(6):1029-1043. PubMed ID: 28144708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of 5-HT
    Tavares LRR; Baptista-de-Souza D; Canto-de-Souza A
    Neuropharmacology; 2018 Jun; 135():376-385. PubMed ID: 29548885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacred Maya incense, copal (Protium copal - Burseraceae), has antianxiety effects in animal models.
    Merali Z; Cayer C; Kent P; Liu R; Cal V; Harris CS; Arnason JT
    J Ethnopharmacol; 2018 Apr; 216():63-70. PubMed ID: 29414121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
    de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J
    Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
    Cagni P; Barros M
    Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT
    Faton S; Tassin JP; Duranton F; Bagnol D; Lajoix AD
    Behav Brain Res; 2018 Jul; 347():234-241. PubMed ID: 29555337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
    Rodgers RJ; Evans PM; Murphy A
    Behav Pharmacol; 2005 Sep; 16(5-6):405-13. PubMed ID: 16148445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
    Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
    Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.